Oligonucleotide competitors for binding of HIV RRE to REV protei

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

536 241, 514 44, C07H 2102, C12Q 168

Patent

active

057861455

ABSTRACT:
A synthetic molecule comprises at least one oligonucleotide comprising an RNA binding sequence or sequences corresponding to the site bound by the HIV protein rev and capable of binding to rev within cells. The binding sequence or sequences, by binding rev within cells, can act to cause inhibition of growth of any HIV present in the cells, and so has potential therapeutic use in treatment of patients infected with HIV. The invention also provides an assay for identifying compounds that inhibit rev binding.

REFERENCES:
patent: 5166195 (1992-11-01), Ecker
patent: 5270163 (1993-12-01), Gold et al.
Proceedings of the National Academy of Sciences of the USA, vol. 87, No. 3, Feb. 1990, (Washington, D.C. US), A.W. Cochrane et al.: "Specific interation of the human immunodeficiency virus REV protein with a structured region in the env mRNA", pp. 1998-1202.
Cell, vol. 60, No. 4, 23 Feb. 1990, Cell Press, S. Heaphy, et al.: "HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region", pp. 685-693.
M. H. Malim et al (1990) Cell 60: 675-683.
C. A. Rosen et al (1990) AIDS 4: 499-509.
J. Lisziewicz et al (1990) J. Cell. Biochem. Supplement 14D, p. 123, Abstract L231.
T.C. Lee et al. (1992) The New Biologist 4(1): 66-74.
Crisey, L.A. ed. Synthecell Synthesis. vol. 2, Issue 1, Rockville, MD: Synthecell Corp., Aug. 1990.
A. Rhodes et al. (1990) J. Gen. Virol. 71: 1965-1974.
M. I. Johnston et al. (1993) Science 260: 1286-1293.
H. Schreier (1994) Pharm. Acta. Helv. 68: 145-159.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Oligonucleotide competitors for binding of HIV RRE to REV protei does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oligonucleotide competitors for binding of HIV RRE to REV protei, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotide competitors for binding of HIV RRE to REV protei will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-22070

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.